We are live on ! Find out more
GC

Grace Capital Portfolio holdings

AUM $168M
1-Year Est. Return 21.6%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$129M
AUM Growth
+$12.5M
Cap. Flow
+$1.51M
Cap. Flow %
1.17%
Top 10 Hldgs %
35.17%
Holding
250
New
36
Increased
56
Reduced
56
Closed
11

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$6.27M
2
AAPL icon
Apple
AAPL
+$3.49M
3
ELUX
AKTIEB. ELECTROLUX B ADR SPNSD
ELUX
+$983K
4
MSGS icon
Madison Square Garden
MSGS
+$769K
5
QQQ icon
Invesco QQQ Trust
QQQ
+$746K

Top Sells

Rank Stock Value
1
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$2.3M
2
MGK icon
Vanguard Morningstar Mega Cap Growth ETF
MGK
+$1.55M
3
SNX icon
TD Synnex
SNX
+$981K
4
GBT
Global Blood Therapeutics, Inc.
GBT
+$883K
5
V icon
Visa
V
+$736K

Sector Composition

Rank Sector Weight
1 Healthcare 23.54%
2 Technology 15.89%
3 Financials 10.33%
4 Consumer Discretionary 9.2%
5 Communication Services 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUN icon
226
Sunoco
SUN
$14.4B
$12K 0.01%
500
– –
BP icon
227
BP
BP
$112B
$10K 0.01%
600
– –
ET icon
228
Energy Transfer Partners
ET
$69.5B
$10K 0.01%
1,920
– –
OXY icon
229
Occidental Petroleum
OXY
$55.7B
$10K 0.01%
1,000
– –
SVC
230
Service Properties Trust
SVC
$1.05B
$10K 0.01%
260
– –
CHX
231
DELISTED
ChampionX
CHX
$9K 0.01%
1,159
– –
MU icon
232
Micron Technology
MU
$835B
$8K 0.01%
175
– –
IBB icon
233
iShares Biotechnology ETF
IBB
$9.45B
$6K ﹤0.01%
50
-700
-93% -$95K
QMCO icon
234
Quantum Corp
QMCO
$411M
$4K ﹤0.01%
50
– –
VKTX icon
235
Viking Therapeutics
VKTX
$3.88B
$4K ﹤0.01%
800
– –
AMLP icon
236
Alerian MLP ETF
AMLP
$12.9B
– –
-12,961
Closed -$320K
EDIT icon
237
Editas Medicine
EDIT
$399M
– –
-111
Closed -$3K
ESGD icon
238
iShares ESG Aware MSCI EAFE ETF
ESGD
$11.7B
– –
-440
Closed -$27K
ESML icon
239
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.79B
– –
-1,200
Closed -$30K
GSIE icon
240
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.9B
– –
-8,300
Closed -$221K
LAMR icon
241
Lamar Advertising Co
LAMR
$16.7B
– –
-1,675
Closed -$112K
VIS icon
242
Vanguard Industrials ETF
VIS
$7.94B
– –
-1,882
Closed -$525K
YARW
243
Yarrow Bioscience, Inc. Common Stock
YARW
$20.3M
– –
-10
Closed -$62K
NS.PRA
244
DELISTED
NuStar Energy L.P. 8.50% Series A Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Units
NS.PRA
– –
-4,000
Closed -$69K
PTLA
245
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-127,729
Closed -$2.3M
INP
246
DELISTED
iPath ETNs Linked to the MSCI India Total Return Index
INP
– –
-7,400
Closed -$477K
6 7 8 9
10

Similar funds

REMS
Real Estate Management Services $167M AUM 37.69% 1-Year Est. Return
TI
Truehand Inc Strafford, New Hampshire $171M AUM 25.9% 1-Year Est. Return
NM
Nokota Management New York $165M AUM
KM
Kylin Management New York $173M AUM 39.51% 1-Year Est. Return
MC
MRJ Capital New York $173M AUM 31.99% 1-Year Est. Return
FAC
Forrestal Agricultural Corporation Princeton, New Jersey $183M AUM
MSO
Madryn Select Opportunities New York $150M AUM
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

Grace Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Grace Capital held 250 positions worth $129M, up 11% from $116M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Grace Capital's Q3 2020 filing shows 36 new, 56 increased, 56 reduced and 11 closed positions. Its largest new stake was Relay Therapeutics: 164,389 shares worth $7M. The largest sale was Portola Pharmaceuticals, Inc., an estimated $2.3M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • Grace Capital's largest Q3 2020 buy was Relay Therapeutics: 164,389 shares worth $7M.
  • Grace Capital added most to Apple in Q3 2020, an estimated $3.49M increase.
  • Grace Capital's biggest Q3 2020 reduction was Vanguard Morningstar Mega Cap Growth ETF, cutting an estimated $1.55M.
  • Grace Capital fully exited Portola Pharmaceuticals, Inc. in Q3 2020, selling an estimated $2.3M.
  • Grace Capital's ten largest holdings make up 35% of its $129M portfolio in Q3 2020.
  • Grace Capital opened 36 new positions and closed 11 in Q3 2020.
  • Grace Capital's portfolio value rose 11% quarter-over-quarter to $129M.

Based on Grace Capital's 13F filing for Q3 2020, filed 12 Nov 2020.